Showing results (21-30 of 71) with videos related to
Sort By:
Pageof 8
Plos One|January 4, 2013
Enhancement of the immunogenicity and protective efficacy of a mucosal influenza subunit vaccine by the saponin adjuvant GPI-0100Heng Liu, Harshad P Patil, Jacqueline de Vries-Idema, et al.Vaccine|January 22, 2011
Preclinical evaluation of the saponin derivative GPI-0100 as an immunostimulating and dose-sparing adjuvant for pandemic influenza vaccinesHeng Liu, Laura Bungener, Wouter ter Veer, et al.The Lancet. Infectious Diseases|October 2, 2010
Needle-free influenza vaccinationJean-Pierre Amorij, Wouter Lj Hinrichs, Henderik W Frijlink, et al.Advanced Drug Delivery Reviews|November 25, 2004
Virosomes for antigen and DNA deliveryToos Daemen, Arjan de Mare, Laura Bungener, et al.Biochimica Et Biophysica Acta|April 25, 2006
Use of a dialyzable short-chain phospholipid for efficient solubilization and reconstitution of influenza virus envelopesJørgen de Jonge, Pieter Schoen, Wouter ter Veer, et al.The AAPS Journal|February 1, 2014
Simplifying influenza vaccination during pandemics: sublingual priming and intramuscular boosting of immune responses with heterologous whole inactivated influenza vaccineSenthil Murugappan, Harshad P Patil, Henderik W Frijlink, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 2, 2006
Recombinant alphaviruses as vectors for anti-tumour and anti-microbial immunotherapyAnnelies Riezebos-Brilman, Arjan de Mare, Laura Bungener, et al.Vaccine|July 20, 2005
The virosome concept for influenza vaccinesAnke Huckriede, Laura Bungener, Toon Stegmann, et al.Vaccine|January 18, 2005
Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activityLaura Bungener, Anke Huckriede, Arjan de Mare, et al.Immunity, Inflammation and Disease|April 23, 2020
Characterization of humoral immune responses and degree of protection induced by influenza vaccine in cotton rats: Effects of low vaccine dose and single vs booster vaccinationYoshita Bhide, Wei Dong, Tjarko Meijerhof, et al.Pageof 8